Heart failure with preserved ejection fraction epidemiology, pathophysiology, diagnosis and treatment strategies

The prevalence of HF with preserved ejection raction (HFpEF, with EF ≥50%) is increasing across all populations with high rates of hospitalization and mortality, reaching up to 80% and 50%, respectively, within a 5-year timeframe. Comorbidity-driven systemic inflammation is thought to cause coronary...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	International journal of cardiology 2024-10, Vol.412, p.132304, Article 132304
Hauptverfasser:	Abdin, Amr, Böhm, Michael, Shahim, Bahira, Karlström, Patric, Kulenthiran, Saarraaken, Skouri, Hadi, Lund, Lars H.
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers - blood Diagnosis and treatment strategies Exercise Glucagon-Like Peptide-1 Receptor Agonists - therapeutic use Heart failure with preserved ejection fraction (HFpEF): epidemiology Heart Failure, Diastolic - diagnosis Heart Failure, Diastolic - epidemiology Heart Failure, Diastolic - physiopathology Heart Failure, Diastolic - therapy Humans Pathophysiology Prevalence Sodium-Glucose Transporter 2 Inhibitors - therapeutic use Stroke Volume
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!